| 000 | 01397 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517040111.0 | ||
| 264 | 0 | _c20170315 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1973-9478 | ||
| 024 | 7 |
_a10.1179/1973947815Y.0000000053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Zexing | |
| 245 | 0 | 0 |
_aRisk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. _h[electronic resource] |
| 260 |
_bJournal of chemotherapy (Florence, Italy) _cAug 2016 |
||
| 300 |
_a328-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIntestinal Perforation _xchemically induced |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aRamucirumab |
| 700 | 1 | _aZhang, Jun | |
| 700 | 1 | _aZhang, Liang | |
| 700 | 1 | _aLiu, Pengying | |
| 700 | 1 | _aXie, Yamin | |
| 700 | 1 | _aZhou, Qin | |
| 773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 28 _gno. 4 _gp. 328-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/1973947815Y.0000000053 _zAvailable from publisher's website |
| 999 |
_c25006004 _d25006004 |
||